S. Kaltenhauser et al., Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity, J RHEUMATOL, 28(4), 2001, pp. 735-744
Objective. A prospective clinical study of patients with recent onset rheum
atoid arthritis (RA) to examine the relationship between inflammatory disea
se activity and joint destruction in a 4 year followup, and to evaluate pro
gnostic markers for severe joint erosions early in the disease.
Methods, Eighty-seven patients with RA according to the American College of
Rheumatology criteria and a disease duration < 2 years were followed for a
n observation time of 2 to 1 years (mean 3.1 yrs). Variables of clinical an
d laboratory disease activity were monitored, and HLA-DRB1 alleles were det
ermined. Hand and foot radiographs were taken every 6 months.
Results. Multivariate analysis of independent contributions of covariates t
o progression of joint destruction resulted in a mixed effect regression mo
del with significant influences for the presence of a shared epitope (SE) p
ositive DR4 allele (SE+ DR4+; p = 0.007), rheumatoid factor (RF) IgA (p = 0
.01), and sex (p = 0.059), but not for clinical variables or acute phase re
actants. The odds ratio to reach a Larsen score above 32 during the observa
tion period of 4 years was increased in patients positive for RF IgM (OR 2.
7, p = 0.019), for the shared epitope on a DR4 allele (OR 8.6, p < 0.005),
and in patients with erosions already at study entry (OR 11.9, p = 0.001).
The highest sensitivity and specificity for the prediction of severe bone d
estruction (84% and 79%) were found when the presence of either a SE+ DR4 a
llele or of early erosions was used as a prognostic marker (OR 20.4. p<0.00
01).
Conclusion, Our results show the pace of joint destruction in RA to be infl
uenced by the presence of SE+ DR4 alleles, RF production, and sex and by th
e presence of erosive disease at presentation. Those prognostic markers exe
rt their influence independently from the inflammatory disease activity.